A new study found that a popular low-calorie sweetener commonly used in sugar-free gum, candies and diet-friendly baked goods ...
1don MSN
Are sugar- controlling low- calorie sweeteners all good? Study says they might wreck your liver
A new study warns that a common low-calorie sweetener called sorbitol may affect the liver when levels get too high. Sorbitol ...
Phase I clinical trials remain essential for new drug development, identifying new treatment pathways, and identifying optimal dosing, the American Society of Clinical Oncology emphasized in a new ...
Winner of the France 2030 plan, POCUSI embodies the French ambition for technological sovereignty in medical imaging. Composed of four national partners, it aims to develop a new generation of ...
A cancer diagnosis six years ago led to Alec Gunn's current health journey. Now the WARM director needs a liver donation.
Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect and slow the condition early.
Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...
One Novant doctor calls the technology phenomenal, and early results indicate it may be suitable to treat other cancers, too.
WINSTON-SALEM — Novant Health is the first health care system in the Carolinas to offer histotripsy, a groundbreaking ...
HistoSonics is developing a non-invasive therapy that uses histotripsy, a therapeutic focused ultrasound energy, to destroy tumors.
Medical Device Network on MSN
Exact Sciences reports outcomes from trial of HCC blood test
Exact Sciences has shared outcomes from the prospective ALTUS trial of its Oncoguard Liver blood test for identifying early-stage hepatocellular carcinoma (HCC), a common form of liver cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results